title: Beta-lactam antibiotics use in intensive care units--the pathophysiological, pharmacokinetic, pharmacodynamic and pharmacoeconomic approach.
authors.forename: Aneta
authors.initials: A
authors.lastname: Perić
authors.forename: Maja
authors.initials: M
authors.lastname: Surbatović
authors.forename: Sandra Vezmar
authors.initials: SV
authors.lastname: Kovacević
authors.forename: Mirjana
authors.initials: M
authors.lastname: Antunović
authors.forename: Milić
authors.initials: M
authors.lastname: Veljović
authors.forename: Ivana
authors.initials: I
authors.lastname: Krstić-Lecić
authors.forename: Dragan
authors.initials: D
authors.lastname: Djordjević
authors.forename: Vesna
authors.initials: V
authors.lastname: Kilibarda
authors.forename: Snjezana
authors.initials: S
authors.lastname: Zeba
authors.forename: Silva
authors.initials: S
authors.lastname: Dobrić
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics / Q000494:pharmacology*; D016638:Critical Illness; D016903:Drug Monitoring; D006801:Humans; D007362:Intensive Care Units; D018805:Sepsis / Q000188:drug therapy; D001618:beta-Lactamases / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D001618:beta-Lactamases